RayKnowChina Research Map
Shortlist0

Army Medical University

陆军军医大学

ChongqingUniversity or health system

Hospitals that carry this university's name, added together, plus papers and trials that name only the university.

Research activity, not treatment quality. Not medical advice. How this works

Nasopharyngeal carcinoma

鼻咽癌
0.4%Leads under 1 in 100 of China's research papers on NPC

Led 10 of 2,375 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (23.4%).

Run this PubMed search

Open trials led
1
Research papers it led
10
Trials it led
6
Share of China's trials
1.0%
Share of the world's papers
0.3%
Papers led per year
2021: 1120212022: 1120222023: 0020232024: 1120242025: 112025
ThemesRadiotherapy techniqueSide effects & quality of lifeImaging & AI

Over half of these papers are lab or animal studies.

Hospitals counted here

  1. Southwest Hospital, Army Medical University3
  2. Xinqiao Hospital, Army Medical University3
  3. Daping Hospital, Army Medical University2

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

Papers it led5
  1. A randomized, controlled phase II trial of maxillofacial and oral massage in attenuating severe radiotherapy-induced oral mucositis and lipid metabolite changes in nasopharyngeal carcinoma.2021Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and OncologyRCT
  2. Population-based nasopharyngeal carcinoma survival in southern China.2026British journal of cancerFree full text
  3. Retrospective study of a novel hematological parameter for predicting the survival of patients with nasopharyngeal carcinoma.2024PeerJFree full text
  4. Evaluation of target autocrop function in nasopharyngeal carcinoma SIB IMRT plan.2022Physical and engineering sciences in medicine
  5. The suffering experiences of patients with nasopharyngeal carcinoma in China: a qualitative study.2025BMJ openFree full text
Trials on ClinicalTrials.gov6
  1. Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal CarcinomaRecruitingNCT05147844Lead sponsorPhase 2Start 2022-03
  2. EBV Specific Cytokine Secreting TCR-T Cells in the Treatment of EBV-Positive Metastatic/Refractory Nasopharyngeal CarcinomaCompletedNCT04509726Lead sponsorPhase 1/Phase 2Start 2023-03
  3. Using Massage of Maxillofacial and Oral Cavity to Prevent Radioactive Oral MucositisCompletedNCT03788499Lead sponsorN/AStart 2019-01
  4. 3DV+TPS Applied to Radiotherapy for Nasopharyngeal CarcinomaCompletedNCT03791944Lead sponsorN/AStart 2018-12
  5. 3DV+TPS Software Outlines the Radiotherapy of Nasopharyngeal CarcinomaCompletedNCT03810274Lead sponsorStart 2012-02
  6. Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal CarcinomaStatus unknownNCT01265147Lead sponsorPhase 2Start 2011-01

PubMed searchClinicalTrials.gov

Oesophageal squamous cell carcinoma

食管鳞状细胞癌
0.4%Leads under 1 in 100 of China's research papers on ESCC ▼ from 1.0%

Led 11 of 2,923 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (6.9%).

Run this PubMed search

Open trials led
2
Research papers it led
11
Trials it led
6
Share of China's trials
1.1%
Share of the world's papers
0.2%
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 0020242025: 552025
ThemesSurgeryNeoadjuvant & combined treatmentMolecular markers & genomics

Hospitals counted here

  1. Daping Hospital, Army Medical University8
  2. Xinqiao Hospital, Army Medical University Counted in the group total2
  3. Army Medical Center1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

Papers it led5
  1. APE1 mediates chemoresistance in esophageal squamous cell carcinoma by remodeling the immunosuppressive microenvironment.2025Frontiers in immunologyFree full text
  2. Three-year outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with locally advanced esophageal squamous cell carcinoma: a real-world retrospective study.2025Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
  3. Anlotinib plus camrelizumab and chemotherapy as first-line treatment in patients with advanced esophageal squamous cell carcinoma.2025Scientific reportsFree full text
  4. Patients with Upper Third of Esophageal Squamous Cell Carcinoma Have Better Tumor Regression After Neoadjuvant Immunochemotherapy.2025Annals of surgical oncology
  5. Laparoscopic jejunostomy during McKeown minimally invasive esophagectomy: a propensity score analysis.2025Surgical endoscopy
Trials on ClinicalTrials.gov6
  1. Indocyanine Green-guided Omental Shield Anastomosis for Cervical Esophagogastric Anastomosis in Minimally Invasive McKeown EsophagectomyNot yet recruitingNCT07376876Lead sponsorPhase 2Start 2026-01
  2. PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDYRecruitingNCT06354140Lead sponsorPhase 2Start 2024-05
  3. PPIO-007 Correlation Analysis of Type II Diabetes Mellitus on Short-term and Long-term Outcomes of Patients With Esophageal Squamous Cell Cancer Undergoing Minimally Invasive EsophagectomyCompletedNCT06333665Lead sponsorStart 2024-02
  4. PPIO-005 The Relationship Between Different Nutritional Pathways and Tumor Outcomes After Minimally Invasive EsophagectomyCompletedNCT06192212Lead sponsorStart 2023-12
  5. PPIO-004 Clinical Application of Efficacy Prediction Model Based on Epigenomics Sequencing Technology in Neoadjuvant Immunotherapy for Esophageal CancerCompletedNCT05880082Lead sponsorPhase 2Start 2023-01
  6. CT and Endoscopic Biopsy Image-Based Deep Learning for Predicting Left Recurrent Laryngeal Nerve Lymph Node Metastasis in Esophageal CancerActive, not recruitingNCT07074535Lead sponsorStart 2019-01

PubMed searchClinicalTrials.gov

Hepatocellular carcinoma

肝细胞癌
0.7%Leads under 1 in 100 of China's research papers on HCC

Led 105 of 14,765 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (5.5%).

Run this PubMed search

Open trials led
0
Research papers it led
105
Trials it led
20
Share of China's trials
1.4%
Share of the world's papers
0.4%
Papers led per year
2021: 0020212022: 1120222023: 2220232024: 1120242025: 112025
ThemesSurgery & liver transplantRecurrence & prognosisLocal treatment (ablation, TACE, HAIC)

Hospitals counted here

  1. Southwest Hospital, Army Medical University57
  2. Xinqiao Hospital, Army Medical University23
  3. Daping Hospital, Army Medical University Counted in the group total13
  4. Army Specialty Medical Center1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

Papers it led5
  1. Intermittent Pringle maneuver combined with controlled low Central venous pressure prolongs hepatic hilum occlusion time in patients with hepatocellular carcinoma complicated by post hepatitis B cirrhosis: a randomized c2023Scandinavian journal of gastroenterologyRCT
  2. Laparoscopic Anatomical Versus Non-anatomical hepatectomy in the Treatment of Hepatocellular Carcinoma: A randomised controlled trial.2022International journal of surgery (London, England)RCT
  3. Blocking PCSK9 suppresses hepatocellular carcinoma immune escape by decreasing FLI1-mediated SPP1 and PD-L1 expression.2025Journal for immunotherapy of cancerFree full text
  4. Anatomic Liver Resection Based on Portal Territory With Margin Priority for Hepatocellular Carcinoma.2024JAMA surgery
  5. A Giant Cystic Liver Mass in an Elderly Man.2023Gastroenterology
Trials on ClinicalTrials.gov6
  1. Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High RiskNot yet recruitingNCT07010588Study siteN/AStart 2025-06
  2. Digital Early Warning System for Acute Lung Injury in Liver SurgeryRecruitingNCT07070362Study siteStart 2024-11
  3. Radiofrequency Ablation Plus Systematic Neoadjuvant Therapy for Recurrent Hepatocellular Carcinoma (RANT Study)Status unknownNCT05277675Lead sponsorN/AStart 2021-11
  4. A Study of Laparoscopic Middle Hepatic Vein Guidance and Traditional Anatomic HemihepatectomyStatus unknownNCT04422249Lead sponsorN/AStart 2019-12
  5. The Short-term Efficacy of Novel NTDP-RFA in the Treatment of Small HCC With Cirrhosis.Status unknownNCT04513119Lead sponsorStart 2017-01
  6. Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT03084380Lead sponsorPhase 1/Phase 2Start 2017-06

PubMed searchClinicalTrials.gov

Stomach cancer

胃癌
0.6%Leads under 1 in 100 of China's research papers on Stomach cancer

Led 56 of 9,782 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (3.9%).

Run this PubMed search

Open trials led
5
Research papers it led
56
Trials it led
15
Share of China's trials
1.0%
Share of the world's papers
0.3%
Papers led per year
2021: 0020212022: 0020222023: 1120232024: 0020242025: 222025
ThemesSurgeryEarly detection & endoscopyPeritoneal spread & advanced disease

Hospitals counted here

  1. Southwest Hospital, Army Medical University23
  2. Xinqiao Hospital, Army Medical University18
  3. Daping Hospital, Army Medical University9
  4. First Affiliated Hospital of the Third Military Medical University2
  5. First Affiliated Hospital of Third Military Medical University Counted in the group total1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

Papers it led5
  1. Magnifying image-enhanced endoscopy-only mode boosted early cancer diagnostic efficiency: a multicenter randomized controlled trial.2023Gastrointestinal endoscopyRCT
  2. Helicobacter pylori CagA elevates FTO to induce gastric cancer progression via a "hit-and-run" paradigm.2025Cancer communications (London, England)Free full text
  3. Clinicopathological features and diagnostic challenges of early gastric cardiac carcinoma with dysplastic gastritis cystica profunda: A case report.2026Pathology, research and practice
  4. Assessment of modified textbook outcomes following gastrectomy based on survival benefits: a multicenter observational study.2026International journal of surgery (London, England)Free full text
  5. Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial.2025Clinical cancer research : an official journal of the American Association for Cancer Research
Trials on ClinicalTrials.gov6
  1. LDRT Sequential NIPS Immunochemotherapy for Peritoneal Metastasis of Gastric and Colorectal CancerNot yet recruitingNCT07453875Lead sponsorPhase 1Start 2026-05
  2. Single-port Robotic Radical Gastrectomy for Gastric CancerRecruitingNCT07237126Lead sponsorN/AStart 2026-07
  3. Robotic Versus Laparoscopic Radical Surgery for Locally Advanced Gastric CancerRecruitingNCT06791538Lead sponsorN/AStart 2025-02
  4. Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)RecruitingNCT07165847Lead sponsorPhase 2Start 2025-07
  5. A Prospective Cohort Study on the Treatment of Locally Advanced Gastric CancerRecruitingNCT06760858Lead sponsorStart 2024-12
  6. Radical Surgery Versus Non-Surgery in Gastric Cancer Patients With Peritoneal Metastasis After Successful Conversion TherapyRecruitingNCT07789184Study sitePhase 3Start 2026-12

PubMed searchClinicalTrials.gov

Retinoblastoma

视网膜母细胞瘤
0.3%Leads under 1 in 100 of China's research papers on Retinoblastoma ▼ from 1.4%

Led 1 of 301 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (12.0%).

Run this PubMed search

Open trials led
0
Research papers it led
1
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.09%
Papers led per year
2021: 1120212022: 0020222023: 0020232024: 0020242025: 002025

Hospitals counted here

  1. Daping Hospital, Army Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Osteosarcoma

骨肉瘤
0.8%Leads under 1 in 100 of China's research papers on Osteosarcoma

Led 18 of 2,257 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (4.3%).

Run this PubMed search

Open trials led
0
Research papers it led
18
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.4%
Papers led per year
2021: 2220212022: 0020222023: 1120232024: 1120242025: 112025

Over half of these papers are lab or animal studies.

Hospitals counted here

  1. Southwest Hospital, Army Medical University7
  2. Xinqiao Hospital, Army Medical University5
  3. Daping Hospital, Army Medical University5

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Gastrointestinal stromal tumour

胃肠道间质瘤
0.2%Leads under 1 in 100 of China's research papers on Gastrointestinal stromal tumour ▼ from 0.8%

Led 1 of 523 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (6.3%).

Run this PubMed search

Open trials led
0
Research papers it led
1
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.06%
Papers led per year
2021: 1120212022: 0020222023: 0020232024: 0020242025: 002025

Hospitals counted here

  1. Southwest Hospital, Army Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Neuroblastoma

神经母细胞瘤
0.0%Leads none of China's research papers on Neuroblastoma

Led 0 of 1,132 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (8.8%).

Run this PubMed search

Open trials led
0
Research papers it led
0
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.0%

PubMed searchClinicalTrials.gov

Multiple myeloma

多发性骨髓瘤
0.3%Leads under 1 in 100 of China's research papers on Myeloma

Led 5 of 1,676 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (4.8%).

Run this PubMed search

Open trials led
0
Research papers it led
5
Trials it led
3
Share of China's trials
0.6%
Share of the world's papers
0.05%
Papers led per year
2021: 0020212022: 0020222023: 3320232024: 0020242025: 112025
ThemesDiagnosis, MRD & riskDrug combinationsRelapse & resistance

Hospitals counted here

  1. Xinqiao Hospital, Army Medical University5

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

Papers it led5
  1. Prognostic value of semi-quantitative parameters of 18F-FDG PET/CT in newly diagnosed multiple myeloma patients.2023Annals of nuclear medicineFree full text
  2. Transcriptome Analysis Identifies Functional and Prognostic Hypoxia-Associated Genes in Multiple Myeloma.2026International journal of laboratory hematology
  3. Identification of Copy Number Alterations From Shallow Whole-Genome Sequencing in Multiple Myeloma.2025Hematological oncology
  4. Lactate Decreases Bortezomib Sensitivity and Predicts Poor Clinical Outcomes of Multiple Myeloma.2023Current medical science
  5. CAR-NK cell therapy for hematological malignancies: recent updates from ASH 2022.2023Journal of hematology & oncologyFree full text
Trials on ClinicalTrials.gov6
  1. Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple MyelomaNot yet recruitingNCT07569757Study sitePhase 3Start 2026-06
  2. Anti-BCMA CAR-NK Cell Therapy for the Relapsed or Refractory Multiple MyelomaStatus unknownNCT05008536Lead sponsorEarly phase 1Start 2021-10
  3. Anti-BCMA CAR-T Cell Therapy for the R/R Multiple MyelomaStatus unknownNCT04637269Lead sponsorEarly phase 1Start 2020-11
  4. A Clinical Research of BCMA-Targeted CAR-T in B Cell MalignanciesStatus unknownNCT02954445Lead sponsorPhase 1/Phase 2Start 2016-10
  5. A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03)Active, not recruitingNCT06464991Study sitePhase 3Start 2024-03
  6. A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)CompletedNCT04939142Study sitePhase 3Start 2021-07

PubMed searchClinicalTrials.gov

B-cell acute lymphoblastic leukaemia (B-ALL)

B 细胞急性淋巴细胞白血病
1.3%Leads about 1 in 75 of China's research papers on B-ALL

Led 3 of 225 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (8.9%).

Run this PubMed search

Open trials led
0
Research papers it led
3
Trials it led
2
Share of China's trials
0.8%
Share of the world's papers
0.3%
Papers led per year
2021: 1120212022: 0020222023: 0020232024: 1120242025: 112025
ThemesCAR-T & cell therapyMRD & relapseChildren

Hospitals counted here

  1. Xinqiao Hospital, Army Medical University3

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Aplastic anaemia

再生障碍性贫血
0.7%Leads under 1 in 100 of China's research papers on Aplastic anaemia

Led 3 of 412 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (17.2%).

Run this PubMed search

Open trials led
0
Research papers it led
3
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.2%
Papers led per year
2021: 0020212022: 1120222023: 0020232024: 1120242025: 112025
ThemesStem cell transplantChildren

Hospitals counted here

  1. Southwest Hospital, Army Medical University2
  2. Xinqiao Hospital, Army Medical University Counted in the group total1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Haemophagocytic lymphohistiocytosis (HLH)

噬血细胞性淋巴组织细胞增生症
1.2%Leads about 1 in 80 of China's research papers on HLH ▲ from 0.5%

Led 5 of 399 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (22.3%).

Run this PubMed search

Open trials led
0
Research papers it led
5
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.3%
Papers led per year
2021: 0020212022: 0020222023: 4420232024: 1120242025: 002025
ThemesLymphoma & cancer-related HLHDiagnosis & prognosisGenetics & inherited forms

Hospitals counted here

  1. Southwest Hospital, Army Medical University2
  2. Daping Hospital, Army Medical University2
  3. Xinqiao Hospital, Army Medical University Counted in the group total1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Moyamoya disease

烟雾病
0.6%Leads under 1 in 100 of China's research papers on Moyamoya New since 2021

Led 2 of 356 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (19.9%).

Run this PubMed search

Open trials led
0
Research papers it led
2
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.2%
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 1120242025: 112025
ThemesImaging & blood flowGenetics

Hospitals counted here

  1. Southwest Hospital, Army Medical University2

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Idiopathic pulmonary fibrosis

特发性肺纤维化
0.3%Leads under 1 in 100 of China's research papers on Idiopathic pulmonary fibrosis

Led 3 of 989 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (4.3%).

Run this PubMed search

Open trials led
0
Research papers it led
3
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.08%
Papers led per year
2021: 1120212022: 1120222023: 1120232024: 0020242025: 002025

Hospitals counted here

  1. Daping Hospital, Army Medical University1
  2. Affiliated Hospital, Army Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Amyotrophic lateral sclerosis

肌萎缩侧索硬化症
0.4%Leads under 1 in 100 of China's research papers on Amyotrophic lateral sclerosis ▼ from 1.3%

Led 3 of 779 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (8.3%).

Run this PubMed search

Open trials led
0
Research papers it led
3
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.05%
Papers led per year
2021: 2220212022: 0020222023: 0020232024: 1120242025: 002025

Hospitals counted here

  1. Daping Hospital, Army Medical University3
  2. Southwest Hospital, Army Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Alport syndrome

Alport 综合征
3.5%Leads about 1 in 29 of China's research papers on Alport syndrome New since 2021

Led 2 of 58 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (17.2%).

Run this PubMed search

Open trials led
0
Research papers it led
2
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.6%
Papers led per year
2021: 1120212022: 0020222023: 0020232024: 1120242025: 002025

Hospitals counted here

  1. Xinqiao Hospital, Army Medical University2

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

IgA nephropathy

IgA 肾病
0.9%Leads under 1 in 100 of China's research papers on IgA nephropathy

Led 7 of 736 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (9.4%).

Run this PubMed search

Open trials led
0
Research papers it led
7
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.4%
Papers led per year
2021: 0020212022: 1120222023: 1120232024: 1120242025: 222025

Hospitals counted here

  1. Xinqiao Hospital, Army Medical University4
  2. Daping Hospital, Army Medical University1
  3. First affiliated hospital, Third Military Medical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Primary biliary cholangitis

原发性胆汁性胆管炎
1.7%Leads about 1 in 60 of China's research papers on Primary biliary cholangitis ▲ from 0.7%

Led 5 of 300 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (12.0%).

Run this PubMed search

Open trials led
0
Research papers it led
5
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.5%
Papers led per year
2021: 0020212022: 1120222023: 3320232024: 1120242025: 002025

Over half of these papers are lab or animal studies.

Hospitals counted here

  1. Southwest Hospital, Army Medical University5

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Congenital diaphragmatic hernia

先天性膈疝
3.3%Leads about 1 in 30 of China's research papers on Congenital diaphragmatic hernia New since 2021

Led 2 of 60 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (18.3%).

Run this PubMed search

Open trials led
0
Research papers it led
2
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.2%
Papers led per year
2021: 0020212022: 2220222023: 0020232024: 0020242025: 002025

Hospitals counted here

  1. Xinqiao Hospital, Army Medical University2

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov